neuroblastoma in a 55-year-old patient: a case report

Clicks: 267
ID: 164449
2010
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Background: Neuroblastomas account for 97% of all neuroblastic tumors and for approximately 15% of all pediatric cancer fatalities. However, in adults neuroblastoma is a very rare finding. Case Report: Here, we present the case of a 55-year-old patient who was diagnosed with neuroblastoma stage IV one year after the false diagnosis of a non-secretory multiple myeloma. Results: The patient received six cycles of a chemotherapy protocol with cisplatin, etoposide and vindesine alternating with vincristine, dacarbazine, ifosfamide and doxorubicin, but the response to treatment was insufficient (stable disease). Conclusion: The standard chemotherapy protocols used for children are not sufficient for adult patients. Different treatment approaches are needed to improve the prognosis of adult patients with neuroblastoma.
Reference Key
then2010caseneuroblastoma Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Cornelia Then;Kathleen Ebelt;Alexandra Langer;Doris Mayr;Ralf Schmidmaier;Fuat Oduncu
Journal multi-span large bridges - proceedings of the international conference on multi-span large bridges, 2015
Year 2010
DOI
10.1159/000322863
URL
http://www.karger.com/Article/FullText/322863
Keywords
Chemotherapy neuroblastoma multiple myeloma Oncology including cancer and carcinogens tumors response to treatmentneoplasms

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.